Skip to Main Content

Author Details

Friedemann Paul
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
1977
592
79
PMIDPaper TitleJournal TitlePublished Year
37676297Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.J Neurol2024
38086777Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.Ann Neurol2024
37721679Digital Motor Biomarkers of Cerebellar Ataxia Using an RGB-Depth Camera-Based Motion Analysis System.Cerebellum2024
37903651Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.Ann Clin Transl Neurol2024
37798094The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis.J Neurol Neurosurg Psychiatry2024
36318271Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis.Eur J Neurol2023
37491849Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.Mult Scler2023
37804003Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.Ann Clin Transl Neurol2023
37854639Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.Mult Scler J Exp Transl Clin2023
37782525Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.J Neuroophthalmol2023
37692259Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.Ther Adv Neurol Disord2023
37881311Progression events defined by home-based assessment of motor function in multiple sclerosis: protocol of a prospective study.Front Neurol2023
37830484Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects.Mult Scler2023
37680475Similar neural pathways link psychological stress and brain-age in health and multiple sclerosis.iScience2023
37573634Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.J Neuroimmunol2023
37641618Functional connectome fingerprinting and stability in multiple sclerosis.Mult Scler J Exp Transl Clin2023
37258412International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.Neurol Neuroimmunol Neuroinflamm2023
37221052Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.J Neurol Neurosurg Psychiatry2023
37219933iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions.J Clin Invest2023
37188221Increased flexibility of brain dynamics in patients with multiple sclerosis.Brain Commun2023
37022481Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.J Neurol2023
37249534Association Between Frailty and Free-Living Walking Performance in People With Multiple Sclerosis.Phys Ther2023
37413855Discrimination of multiple sclerosis using OCT images from two different centers.Mult Scler Relat Disord2023
37282545Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.Mult Scler2023
37140218Immunomodulatory Effects of New Phenanthrene Derivatives from <i>Dendrobium crumenatum</i>.J Nat Prod2023
37140003HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation.Glia2023
37433662Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.J Neurol Neurosurg Psychiatry2023
37297838Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study.J Clin Med2023
37431144Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.Mult Scler2023
37396922Fighting Post-COVID and ME/CFS - development of curative therapies.Front Med (Lausanne)2023
36923535First <i>in vivo</i> fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.Theranostics2023
36786424Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).Mult Scler2023
36693760Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.Neurol Neuroimmunol Neuroinflamm2023
36878713Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort.Neurol Neuroimmunol Neuroinflamm2023
36810323Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2023
36515716[Autoimmune encephalitis-An update].Nervenarzt2023
36515653Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.Brain2023
36807557Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.Sci Rep2023
36873426Structural brain changes in patients with post-COVID fatigue: a prospective observational study.EClinicalMedicine2023
36908609The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.Front Neurol2023
36866852Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.Ann Neurol2023
36635219Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.Eur J Neurol2023
36700353Multiple sclerosis and circadian rhythms: Can diet act as a treatment?Acta Physiol (Oxf)2023
36357586Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial.J Neurol2023
36378751Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.Expert Rev Clin Immunol2023
36319190Association of obesity with disease outcome in multiple sclerosis.J Neurol Neurosurg Psychiatry2023
34711650Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2022
35772194Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.Neuroimage Clin2022
35507058Fibrin-targeting molecular MRI in inflammatory CNS disorders.Eur J Nucl Med Mol Imaging2022
35363150Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study.JMIR Hum Factors2022
  • 1 - 50 of 592

Recommended Authors

Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen
Career Start Year 2017
Number of shared co-authors 0
University of Padua
Career Start Year 2015
Number of shared co-authors 0
University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 2
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 9
Department of Emergency Medicine Vanderbilt University Medical Center Nashville TN.
Career Start Year 2011
Number of shared co-authors 1
University of Virginia Medical Center
Career Start Year 2008
Number of shared co-authors 0
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 1
Boston Children's Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 3
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 12
Yale University
Career Start Year 2005
Number of shared co-authors 6
University of Verona: Via S. Francesco
Career Start Year 2003
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 1
University of California san francisco
Career Start Year 1997
Number of shared co-authors 15
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 5
University of Massachusetts Medical School
Career Start Year 1993
Number of shared co-authors 9
University of Pennsylvania/Ophthalmology
Career Start Year 1993
Number of shared co-authors 7
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Royal Free Hospital
Career Start Year 1991
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 1991
Number of shared co-authors 11
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 4
McMaster University
Career Start Year 1991
Number of shared co-authors 0
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 0
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 10
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1984
Number of shared co-authors 5
Southend Hospital NHS Trust
Career Start Year 1983
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
UK Dementia Research Institute Centre at Imperial College London
Career Start Year 1981
Number of shared co-authors 13
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 1

Collaborators

Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 182
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 96
Co-authored papers 52
Charite School of Medicine and University Hospital Berlin
Co-authored papers 48
Co-authored papers 32
Co-authored papers 30
Hospital Clinic of Barcelona-Institut d'Investigacions
Co-authored papers 27
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Co-authored papers 27
Technical University of Munich
Co-authored papers 25
Co-authored papers 24
Moorfields Eye Hospital
Co-authored papers 21
Fundacio Recerca Clinic Barcelona -IDIBAPS
Co-authored papers 16
Johns Hopkins University School of Medicine
Co-authored papers 14
Johns Hopkins University School of Medicine
Co-authored papers 14
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 12
Vrije Universiteit Amsterdam
Co-authored papers 12
Technical University of Munich
Co-authored papers 11
TUM School of Medicine, Technical University of Munich
Co-authored papers 10
Vita-Salute University & Hospital San Raffaele
Co-authored papers 10
Co-authored papers 10
University Hospital Basel
Co-authored papers 9
Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem
Co-authored papers 8
University of Alabama at Birmingham
Co-authored papers 8
Co-authored papers 8
Stanford University School of Medicine
Co-authored papers 8
Co-authored papers 8
Stanford University School of Medicine
Co-authored papers 7
Oxford University
Co-authored papers 7
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 6
Co-authored papers 5